The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diabetes Management Products-Global Market Insights and Sales Trends 2024
Synopsis
Diabetes Management Products are designed to restore carbohydrate metabolism to a normal state as much as possible through treatment or prevention.
The global Diabetes Management Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Management Products in various end use industries. The expanding demands from the Hospitals, Medical Clinics and Others,, are propelling Diabetes Management Products market. Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mobile Apps segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Management Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Management Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Management Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Management Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Management Products covered in this report include Medtronic, B. Braun, Dexcom, Roche Diagnostics, Insulet Corporation, Ascensia Diabetes Care, LifeScan, Tidepool and AgaMatrix, etc.
The global Diabetes Management Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
B. Braun
Dexcom
Roche Diagnostics
Insulet Corporation
Ascensia Diabetes Care
LifeScan
Tidepool
AgaMatrix
Glooko
DarioHealth
Welldoc
Semma Therapeutics
Omada Health
Global Diabetes Management Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Management Products market, Segment by Type:
Device
Mobile Apps
Service
Data Management Software
Global Diabetes Management Products market, by Application
Hospitals
Medical Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Management Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes Management Products are designed to restore carbohydrate metabolism to a normal state as much as possible through treatment or prevention.
The global Diabetes Management Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Management Products in various end use industries. The expanding demands from the Hospitals, Medical Clinics and Others,, are propelling Diabetes Management Products market. Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mobile Apps segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Management Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Management Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Management Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Management Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Management Products covered in this report include Medtronic, B. Braun, Dexcom, Roche Diagnostics, Insulet Corporation, Ascensia Diabetes Care, LifeScan, Tidepool and AgaMatrix, etc.
The global Diabetes Management Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
B. Braun
Dexcom
Roche Diagnostics
Insulet Corporation
Ascensia Diabetes Care
LifeScan
Tidepool
AgaMatrix
Glooko
DarioHealth
Welldoc
Semma Therapeutics
Omada Health
Global Diabetes Management Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Management Products market, Segment by Type:
Device
Mobile Apps
Service
Data Management Software
Global Diabetes Management Products market, by Application
Hospitals
Medical Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Management Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diabetes Management Products
1.1 Diabetes Management Products Market Overview
1.1.1 Diabetes Management Products Product Scope
1.1.2 Diabetes Management Products Market Status and Outlook
1.2 Global Diabetes Management Products Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diabetes Management Products Market Size by Region (2018-2029)
1.4 Global Diabetes Management Products Historic Market Size by Region (2018-2023)
1.5 Global Diabetes Management Products Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diabetes Management Products Market Size (2018-2029)
1.6.1 North America Diabetes Management Products Market Size (2018-2029)
1.6.2 Europe Diabetes Management Products Market Size (2018-2029)
1.6.3 Asia-Pacific Diabetes Management Products Market Size (2018-2029)
1.6.4 Latin America Diabetes Management Products Market Size (2018-2029)
1.6.5 Middle East & Africa Diabetes Management Products Market Size (2018-2029)
2 Diabetes Management Products Market by Type
2.1 Introduction
2.1.1 Device
2.1.2 Mobile Apps
2.1.3 Service
2.1.4 Data Management Software
2.2 Global Diabetes Management Products Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diabetes Management Products Historic Market Size by Type (2018-2023)
2.2.2 Global Diabetes Management Products Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diabetes Management Products Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diabetes Management Products Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diabetes Management Products Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diabetes Management Products Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diabetes Management Products Revenue Breakdown by Type (2018-2029)
3 Diabetes Management Products Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Medical Clinics
3.1.3 Others
3.2 Global Diabetes Management Products Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diabetes Management Products Historic Market Size by Application (2018-2023)
3.2.2 Global Diabetes Management Products Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diabetes Management Products Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diabetes Management Products Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diabetes Management Products Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diabetes Management Products Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diabetes Management Products Revenue Breakdown by Application (2018-2029)
4 Diabetes Management Products Competition Analysis by Players
4.1 Global Diabetes Management Products Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Management Products as of 2022)
4.3 Date of Key Players Enter into Diabetes Management Products Market
4.4 Global Top Players Diabetes Management Products Headquarters and Area Served
4.5 Key Players Diabetes Management Products Product Solution and Service
4.6 Competitive Status
4.6.1 Diabetes Management Products Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic
5.1.1 Medtronic Profile
5.1.2 Medtronic Main Business
5.1.3 Medtronic Diabetes Management Products Products, Services and Solutions
5.1.4 Medtronic Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic Recent Developments
5.2 B. Braun
5.2.1 B. Braun Profile
5.2.2 B. Braun Main Business
5.2.3 B. Braun Diabetes Management Products Products, Services and Solutions
5.2.4 B. Braun Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.2.5 B. Braun Recent Developments
5.3 Dexcom
5.3.1 Dexcom Profile
5.3.2 Dexcom Main Business
5.3.3 Dexcom Diabetes Management Products Products, Services and Solutions
5.3.4 Dexcom Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostics Recent Developments
5.4 Roche Diagnostics
5.4.1 Roche Diagnostics Profile
5.4.2 Roche Diagnostics Main Business
5.4.3 Roche Diagnostics Diabetes Management Products Products, Services and Solutions
5.4.4 Roche Diagnostics Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostics Recent Developments
5.5 Insulet Corporation
5.5.1 Insulet Corporation Profile
5.5.2 Insulet Corporation Main Business
5.5.3 Insulet Corporation Diabetes Management Products Products, Services and Solutions
5.5.4 Insulet Corporation Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.5.5 Insulet Corporation Recent Developments
5.6 Ascensia Diabetes Care
5.6.1 Ascensia Diabetes Care Profile
5.6.2 Ascensia Diabetes Care Main Business
5.6.3 Ascensia Diabetes Care Diabetes Management Products Products, Services and Solutions
5.6.4 Ascensia Diabetes Care Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.6.5 Ascensia Diabetes Care Recent Developments
5.7 LifeScan
5.7.1 LifeScan Profile
5.7.2 LifeScan Main Business
5.7.3 LifeScan Diabetes Management Products Products, Services and Solutions
5.7.4 LifeScan Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.7.5 LifeScan Recent Developments
5.8 Tidepool
5.8.1 Tidepool Profile
5.8.2 Tidepool Main Business
5.8.3 Tidepool Diabetes Management Products Products, Services and Solutions
5.8.4 Tidepool Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.8.5 Tidepool Recent Developments
5.9 AgaMatrix
5.9.1 AgaMatrix Profile
5.9.2 AgaMatrix Main Business
5.9.3 AgaMatrix Diabetes Management Products Products, Services and Solutions
5.9.4 AgaMatrix Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.9.5 AgaMatrix Recent Developments
5.10 Glooko
5.10.1 Glooko Profile
5.10.2 Glooko Main Business
5.10.3 Glooko Diabetes Management Products Products, Services and Solutions
5.10.4 Glooko Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.10.5 Glooko Recent Developments
5.11 DarioHealth
5.11.1 DarioHealth Profile
5.11.2 DarioHealth Main Business
5.11.3 DarioHealth Diabetes Management Products Products, Services and Solutions
5.11.4 DarioHealth Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.11.5 DarioHealth Recent Developments
5.12 Welldoc
5.12.1 Welldoc Profile
5.12.2 Welldoc Main Business
5.12.3 Welldoc Diabetes Management Products Products, Services and Solutions
5.12.4 Welldoc Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.12.5 Welldoc Recent Developments
5.13 Semma Therapeutics
5.13.1 Semma Therapeutics Profile
5.13.2 Semma Therapeutics Main Business
5.13.3 Semma Therapeutics Diabetes Management Products Products, Services and Solutions
5.13.4 Semma Therapeutics Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.13.5 Semma Therapeutics Recent Developments
5.14 Omada Health
5.14.1 Omada Health Profile
5.14.2 Omada Health Main Business
5.14.3 Omada Health Diabetes Management Products Products, Services and Solutions
5.14.4 Omada Health Diabetes Management Products Revenue (US$ Million) & (2018-2023)
5.14.5 Omada Health Recent Developments
6 North America
6.1 North America Diabetes Management Products Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diabetes Management Products Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Management Products Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diabetes Management Products Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Management Products Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diabetes Management Products Market Dynamics
11.1 Diabetes Management Products Industry Trends
11.2 Diabetes Management Products Market Drivers
11.3 Diabetes Management Products Market Challenges
11.4 Diabetes Management Products Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
